Corrigendum to "PGE2 protects against heart failure through inhibiting TGF-β1 synthesis in cardiomyocytes and crosstalk between TGF-β1 and GRK2" [Journal of Molecular and Cellular Cardiology. 172(2022) 63-77].

MLA

Fu, Jing, et al. “Corrigendum to ‘PGE2 Protects against Heart Failure through Inhibiting TGF-Β1 Synthesis in Cardiomyocytes and Crosstalk between TGF-Β1 and GRK2’ [Journal of Molecular and Cellular Cardiology. 172(2022) 63-77].” Journal of Molecular and Cellular Cardiology, vol. 199, Feb. 2025, p. 80. EBSCOhost, https://doi.org/10.1016/j.yjmcc.2024.11.003.

APA

Fu, J., Li, L., Chen, L., Su, C., Feng, X., Huang, K., Zhang, L., Yang, X., & Fu, Q. (2025). Corrigendum to “PGE2 protects against heart failure through inhibiting TGF-β1 synthesis in cardiomyocytes and crosstalk between TGF-β1 and GRK2” [Journal of Molecular and Cellular Cardiology. 172(2022) 63-77]. Journal of Molecular and Cellular Cardiology, 199, 80. https://doi.org/10.1016/j.yjmcc.2024.11.003

Chicago

Fu, Jing, Li Li, Long Chen, Congping Su, Xiuling Feng, Kai Huang, Laxi Zhang, Xiaoyan Yang, and Qin Fu. 2025. “Corrigendum to ‘PGE2 Protects against Heart Failure through Inhibiting TGF-Β1 Synthesis in Cardiomyocytes and Crosstalk between TGF-Β1 and GRK2’ [Journal of Molecular and Cellular Cardiology. 172(2022) 63-77].” Journal of Molecular and Cellular Cardiology 199 (February): 80. doi:10.1016/j.yjmcc.2024.11.003.